| Literature DB >> 28945198 |
Aurélie Méneret1,2, Elizabeth A Franz3, Oriane Trouillard1, Thomas C Oliver4, Yvrick Zagar5, Stephen P Robertson6, Quentin Welniarz1,7, R J MacKinlay Gardner6, Cécile Gallea1, Myriam Srour8,9, Christel Depienne1,10,11, Christine L Jasoni12, Caroline Dubacq7, Florence Riant13,14, Jean-Charles Lamy1, Marie-Pierre Morel7, Raphael Guérois15, Jessica Andreani15, Coralie Fouquet7, Mohamed Doulazmi16, Marie Vidailhet1,2, Guy A Rouleau8,17,18, Alexis Brice1,19, Alain Chédotal5, Isabelle Dusart7, Emmanuel Roze1,2, David Markie4.
Abstract
Netrin-1 is a secreted protein that was first identified 20 years ago as an axon guidance molecule that regulates midline crossing in the CNS. It plays critical roles in various tissues throughout development and is implicated in tumorigenesis and inflammation in adulthood. Despite extensive studies, no inherited human disease has been directly associated with mutations in NTN1, the gene coding for netrin-1. Here, we have identified 3 mutations in exon 7 of NTN1 in 2 unrelated families and 1 sporadic case with isolated congenital mirror movements (CMM), a disorder characterized by involuntary movements of one hand that mirror intentional movements of the opposite hand. Given the diverse roles of netrin-1, the absence of manifestations other than CMM in NTN1 mutation carriers was unexpected. Using multimodal approaches, we discovered that the anatomy of the corticospinal tract (CST) is abnormal in patients with NTN1-mutant CMM. When expressed in HEK293 or stable HeLa cells, the 3 mutated netrin-1 proteins were almost exclusively detected in the intracellular compartment, contrary to WT netrin-1, which is detected in both intracellular and extracellular compartments. Since netrin-1 is a diffusible extracellular cue, the pathophysiology likely involves its loss of function and subsequent disruption of axon guidance, resulting in abnormal decussation of the CST.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28945198 PMCID: PMC5663368 DOI: 10.1172/JCI95442
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808